High-Throughput miRNA and mRNA Sequencing of Paired Colorectal Normal, Tumor and Metastasis Tissues and Bioinformatic Modeling of miRNA-1 Therapeutic Applications

MiRNAs are discussed as diagnostic and therapeutic molecules. However, effective miRNA drug treatments with miRNAs are, so far, hampered by the complexity of the miRNA networks. To identify potential miRNA drugs in colorectal cancer, we profiled miRNA and mRNA expression in matching normal, tumor and metastasis tissues of eight patients by Illumina sequencing. We validated six miRNAs in a large tissue screen containing 16 additional tumor entities and identified miRNA-1, miRNA-129, miRNA-497 and miRNA-215 as constantly de-regulated within the majority of cancers. Of these, we investigated miRNA-1 as representative in a systems-biology simulation of cellular cancer models implemented in PyBioS and assessed the effects of depletion as well as overexpression in terms of miRNA-1 as a potential treatment option. In this system, miRNA-1 treatment reverted the disease phenotype with different effectiveness among the patients. Scoring the gene expression changes obtained through mRNA-Seq from the same patients we show that the combination of deep sequencing and systems biological modeling can help to identify patient-specific responses to miRNA treatments. We present this data as guideline for future pre-clinical assessments of new and personalized therapeutic options.

[1]  E. Miska,et al.  MicroRNA—implications for cancer , 2007, Virchows Archiv.

[2]  H. Lehrach,et al.  Modeling of miRNA and Drug Action in the EGFR Signaling Pathway , 2012, PloS one.

[3]  Alexander E. Kel,et al.  TRANSFAC® and its module TRANSCompel®: transcriptional gene regulation in eukaryotes , 2005, Nucleic Acids Res..

[4]  T. Golub,et al.  Impaired microRNA processing enhances cellular transformation and tumorigenesis , 2007, Nature Genetics.

[5]  Axel Kowald,et al.  Systems Biology - a Textbook , 2016 .

[6]  Luigi Atzori,et al.  MiR-1 Downregulation Cooperates with MACC1 in Promoting MET Overexpression in Human Colon Cancer , 2011, Clinical Cancer Research.

[7]  Brian S. Roberts,et al.  The colorectal microRNAome. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Andriani Daskalaki,et al.  Prediction in the face of uncertainty: a Monte Carlo-based approach for systems biology of cancer treatment. , 2012, Mutation research.

[9]  Y. Akao,et al.  let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. , 2006, Biological & pharmaceutical bulletin.

[10]  Yangde Zhang,et al.  Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells , 2011, Molecular and Cellular Biochemistry.

[11]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[12]  T. Kwok,et al.  The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras. , 2009, Carcinogenesis.

[13]  Ying Feng,et al.  Supplemental Data P53-mediated Activation of Mirna34 Candidate Tumor-suppressor Genes , 2022 .

[14]  E. Kure,et al.  Differential Expression of miRNAs in Colorectal Cancer: Comparison of Paired Tumor Tissue and Adjacent Normal Mucosa Using High-Throughput Sequencing , 2012, PloS one.

[15]  A. Schetter,et al.  MicroRNAs and Inflammation in the Pathogenesis and Progression of Colon Cancer , 2012, Digestive Diseases.

[16]  Ralf Herwig,et al.  ConsensusPathDB: toward a more complete picture of cell biology , 2010, Nucleic Acids Res..

[17]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[18]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[19]  C. Steer,et al.  MicroRNA‐143 reduces viability and increases sensitivity to 5‐fluorouracil in HCT116 human colorectal cancer cells , 2009, The FEBS journal.

[20]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[21]  Matthew A. Titmus,et al.  Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells , 2010, Molecular Cancer.

[22]  E. Olson,et al.  Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. , 2010, Cancer cell.

[23]  X. Agirre,et al.  Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues , 2006, Molecular Cancer.

[24]  M. Toyota,et al.  Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer. , 2011, Cancer research.

[25]  Lior Pachter,et al.  Identification of novel transcripts in annotated genomes using RNA-Seq , 2011, Bioinform..

[26]  C. Croce,et al.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[28]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[29]  J. Qu,et al.  MicroRNA-1/206 Targets c-Met and Inhibits Rhabdomyosarcoma Development* , 2009, The Journal of Biological Chemistry.

[30]  Thomas D. Schmittgen,et al.  Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. , 2008, Cancer research.

[31]  Fabian J Theis,et al.  PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes , 2010, Genome Biology.

[32]  F. Slack,et al.  RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.

[33]  Reuven Agami,et al.  Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. , 2008, Cancer research.

[34]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[35]  Zhongqiu Wang,et al.  MicroRNA-143 Targets MACC1 to Inhibit Cell Invasion and Migration in Colorectal cancer , 2012, Molecular Cancer.

[36]  Bo Song,et al.  miR-192 Regulates Dihydrofolate Reductase and Cellular Proliferation through the p53-microRNA Circuit , 2008, Clinical Cancer Research.

[37]  George A Calin,et al.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. , 2008, JAMA.

[38]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[39]  Lior Pachter,et al.  Sequence Analysis , 2020, Definitions.

[40]  R. Vyzula,et al.  Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer , 2008, Oncology.

[41]  Jian-Fu Chen,et al.  The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation , 2006, Nature Genetics.

[42]  Joachim Diebold,et al.  c-MYC Delays Prometaphase by Direct Transactivation of MAD2 and BubR1: Identification of Mechanisms Underlying c-MYC-Induced DNA Damage and Chromosomal Instability , 2007, Cell cycle.

[43]  Lincoln Stein,et al.  Reactome: a database of reactions, pathways and biological processes , 2010, Nucleic Acids Res..

[44]  Norbert Gretz,et al.  miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes , 2011, J. Biomed. Informatics.

[45]  J. Pekow,et al.  MicroRNAs in inflammatory bowel disease , 2012, Inflammatory bowel diseases.

[46]  H. Lehrach,et al.  Resources, standards and tools for systems biology. , 2007, Briefings in functional genomics & proteomics.

[47]  Hong Chen,et al.  Preliminary validation of ERBB2 expression regulated by miR-548d-3p and miR-559. , 2009, Biochemical and biophysical research communications.

[48]  Y. Wang,et al.  Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells , 2009, Oncogene.

[49]  W. J. Kent,et al.  BLAT--the BLAST-like alignment tool. , 2002, Genome research.

[50]  Ann L Oberg,et al.  Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states , 2009, BMC Cancer.

[51]  Shunsuke Noguchi,et al.  Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells. , 2011, Cancer letters.

[52]  Xiaoxia Qi,et al.  Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA , 2007, Science.